Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WDR86 antisense RNA 1 (WDR86-AS1) is a long noncoding RNA (lncRNA) gene located on chromosome 7, transcribed in the antisense orientation relative to the WDR86 gene[1][3]. It does not encode a protein but may regulate the expression of its sense counterpart gene (WDR86) through mechanisms such as transcriptional interference and chromatin modification typical of natural antisense transcripts (NATs)[2][4]. WDR86-AS1 has been cataloged in several genomic databases (HGNC, Ensembl, NCBI), and, like other antisense lncRNAs, may play roles in gene expression modulation in health and disease; however, its specific physiological or pathological roles remain poorly characterized. Diseases linked with WDR86-AS1 in gene databases include forms of hypophosphatasia, though these are informatic associations and direct mechanistic links are not established[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WDR86 antisense RNA 1 (WDR86-AS1).